Stock Price
4.72
Daily Change
0.20 4.42%
Monthly
-18.62%
Yearly
-5.79%
Q1 Forecast
4.72

Silence Therapeutics reported $159K in Sales Revenues for its fiscal quarter ending in March of 2025.





Sales Change Date
AstraZeneca USD 15.19B 733M Sep/2025
Autolus Therapeutics Ltd USD 22.61M 1.71M Sep/2025
Hikma Pharmaceutical USD 829M 758M Jun/2025
Novartis USD 13.91B 144M Sep/2025
Roche Holding CHF 15.65B 274.5M Dec/2025
Silence Therapeutics USD 159K 983K Mar/2025